Viewing nowClod 75 mg (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 201405255 · Approved 2014.11.10 · Insurance code 628900300
Improvement of atherosclerotic symptoms and prevention of thromboembolism in atrial fibrillation
This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also helps reduce complications due to cardiovascular issues in patients with acute coronary syndrome who have unstable angina or non-Q wave myocardial infarction and are undergoing or are scheduled to undergo medical therapy, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG). Additionally, it is used to reduce the risk of stroke and thromboembolism in patients with atrial fibrillation who have one or more vascular risk factors and where the use of vitamin K antagonists is not appropriate and the bleeding risk is low. In summary, this medication is used to enhance cardiovascular health by improving atherosclerosis and thrombus formation related to major vascular diseases.
○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine once daily on the first day of treatment, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease with a bleeding diathesis is limited. This medicine may be taken with or without food.
This medication helps blood flow by inhibiting the aggregation of platelets. It must be converted to its active form in the liver to be effective. Some people may genetically have a reduced function of the enzyme that activates this drug. In such cases, the efficacy of the drug may be diminished, leading to more frequent cardiovascular issues such as heart attack or stroke, and alternative treatment options should be considered for these patients. Additionally, medications that activate specific enzymes taken with this drug can increase the concentration of the active ingredient, raising the bleeding risk; therefore, concomitant use should be avoided. This drug should not be used if you are allergic to it, currently have a bleeding condition, have severe liver dysfunction, or are breastfeeding. Patients with a high risk of bleeding, such as those with a history of bleeding or abnormalities in blood coagulation, should use this medication with caution, and it should be discontinued 5-7 days prior to surgery and resumed after bleeding has stopped. Care should be taken when using this drug with other bleeding-risk medications, especially when combined with aspirin, as it may increase the risk of bleeding, and you should follow your doctor's instructions. If symptoms of bleeding (e.g., bruising, nosebleeds, bloody stools, etc.) occur while taking this medication, inform your healthcare provider immediately. The risk to the fetus during pregnancy has not been confirmed, but the risk of bleeding during delivery may be increased, so caution is advised. If you are breastfeeding, discuss with your doctor whether to discontinue breastfeeding due to the potential transfer of the medication into breast milk. Safety in children has not been established, so it's best not to use this medication in pediatric patients. Elderly patients or those with impaired kidney function may have a higher risk of bleeding, so careful monitoring and dosage adjustment is recommended. In case of overdose, bleeding time may prolong and bleeding may occur, and as there is no specific antidote, platelet transfusions may be necessary in case of bleeding. This medication should be kept out of reach of children, and transferring it to another container may alter its quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, and should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy for a longer period.
Pink round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.